These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 16892386)
1. The nuclear receptor superfamily and drug discovery. Moore JT; Collins JL; Pearce KH ChemMedChem; 2006 May; 1(5):504-23. PubMed ID: 16892386 [No Abstract] [Full Text] [Related]
2. Principles for modulation of the nuclear receptor superfamily. Gronemeyer H; Gustafsson JA; Laudet V Nat Rev Drug Discov; 2004 Nov; 3(11):950-64. PubMed ID: 15520817 [TBL] [Abstract][Full Text] [Related]
3. [Transcriptional control by nuclear receptors and its application to drug development]. Kato S Tanpakushitsu Kakusan Koso; 2000 Apr; 45(6 Suppl):950-5. PubMed ID: 10771656 [No Abstract] [Full Text] [Related]
4. Overview of nomenclature of nuclear receptors. Germain P; Staels B; Dacquet C; Spedding M; Laudet V Pharmacol Rev; 2006 Dec; 58(4):685-704. PubMed ID: 17132848 [TBL] [Abstract][Full Text] [Related]
5. Design of selective nuclear receptor modulators: RAR and RXR as a case study. de Lera AR; Bourguet W; Altucci L; Gronemeyer H Nat Rev Drug Discov; 2007 Oct; 6(10):811-20. PubMed ID: 17906643 [TBL] [Abstract][Full Text] [Related]
6. International Union of Pharmacology. LXVI. Orphan nuclear receptors. Benoit G; Cooney A; Giguere V; Ingraham H; Lazar M; Muscat G; Perlmann T; Renaud JP; Schwabe J; Sladek F; Tsai MJ; Laudet V Pharmacol Rev; 2006 Dec; 58(4):798-836. PubMed ID: 17132856 [TBL] [Abstract][Full Text] [Related]
7. Ligand-based approach to in silico pharmacology: nuclear receptor profiling. Mestres J; Martín-Couce L; Gregori-Puigjané E; Cases M; Boyer S J Chem Inf Model; 2006; 46(6):2725-36. PubMed ID: 17125212 [TBL] [Abstract][Full Text] [Related]
8. Panning for SNuRMs: using cofactor profiling for the rational discovery of selective nuclear receptor modulators. Kremoser C; Albers M; Burris TP; Deuschle U; Koegl M Drug Discov Today; 2007 Oct; 12(19-20):860-9. PubMed ID: 17933688 [TBL] [Abstract][Full Text] [Related]
9. Development of assays for nuclear receptor modulators using fluorescently tagged proteins. Martinez ED; Hager GL Methods Enzymol; 2006; 414():37-50. PubMed ID: 17110185 [TBL] [Abstract][Full Text] [Related]
10. Chemical biology of steroid and nuclear hormone receptors. Biggins JB; Koh JT Curr Opin Chem Biol; 2007 Feb; 11(1):99-110. PubMed ID: 17188557 [TBL] [Abstract][Full Text] [Related]
11. International Union of Pharmacology. LXV. The pharmacology and classification of the nuclear receptor superfamily: glucocorticoid, mineralocorticoid, progesterone, and androgen receptors. Lu NZ; Wardell SE; Burnstein KL; Defranco D; Fuller PJ; Giguere V; Hochberg RB; McKay L; Renoir JM; Weigel NL; Wilson EM; McDonnell DP; Cidlowski JA Pharmacol Rev; 2006 Dec; 58(4):782-97. PubMed ID: 17132855 [No Abstract] [Full Text] [Related]
12. The nuclear receptor superfamily: a rosetta stone for physiology. Evans RM Mol Endocrinol; 2005 Jun; 19(6):1429-38. PubMed ID: 15914712 [No Abstract] [Full Text] [Related]
13. 3D QSAR comparative molecular field analysis on nonsteroidal farnesoid X receptor activators. Honório KM; Garratt RC; Polikarpov I; Andricopulo AD J Mol Graph Model; 2007 Mar; 25(6):921-7. PubMed ID: 17055759 [TBL] [Abstract][Full Text] [Related]
19. Small molecule intercalation with double stranded DNA: implications for normal gene regulation and for predicting the biological efficacy and genotoxicity of drugs and other chemicals. Hendry LB; Mahesh VB; Bransome ED; Ewing DE Mutat Res; 2007 Oct; 623(1-2):53-71. PubMed ID: 17449065 [TBL] [Abstract][Full Text] [Related]